Nitrotyrosine Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Nitrotyrosine monoclonal antibodies for advanced research in oxidative stress and nitrosative damage. Nitrotyrosine monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nitrotyrosine is a post-translational modification that occurs when tyrosine residues in proteins are nitrated, often as a result of reactive nitrogen species. This modification plays a key role in various diseases, including neurodegenerative disorders and cardiovascular diseases, serving as a biomarker for oxidative stress and inflammation. Understanding Nitrotyrosine's role in cellular processes helps researchers uncover disease mechanisms and develop therapeutic strategies. Nitrotyrosine modifications can significantly impact protein function and cellular signaling pathways, making their detection and quantification essential for understanding disease progression. Investigating Nitrotyrosine's presence in biological samples provides valuable insights into oxidative damage and inflammatory responses. Research utilizing Nitrotyrosine monoclonal antibodies from Santa Cruz Biotechnology continues to advance our understanding of disease mechanisms and potential therapeutic interventions in the scientific community.